• Explore /
  • Poster
  • / Phase I/II study of T-DM1 alone versus T-DM1 and metronomic temozolomide in secondary prevention of HER2-positive breast cancer brain metastases following stereotactic radiosurgery.

Phase I/II study of T-DM1 alone versus T-DM1 and metronomic temozolomide in secondary prevention of HER2-positive breast cancer brain metastases following stereotactic radiosurgery.

Abstract Video & Slides Poster

Authors

Alexandra Zimmer

Alexandra Dos Santos Zimmer

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Alexandra Dos Santos Zimmer , Seth M. Steinberg , DeeDee Kay Smart , Mark R. Gilbert , Terri Armstrong , Eric Burton , Nicole D. Houston , Nadia Biassou , Brunilde Gril , Priscilla Kaliopi Brastianos , Scott L Carter , David Lyden , Stanley Lipkowitz , Patricia Schriver Steeg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Brain Metastases

Clinical Trial Registration Number

NCT03190967

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS2572)

DOI

10.1200/JCO.2020.38.15_suppl.TPS2572

Abstract #

TPS2572

Poster Bd #

63

Abstract Disclosures

Similar Posters

First Author: Colette Shen

First Author: Ian E. Krop

First Author: Guy Heinrich Maria Jerusalem

First Author: Hossein Borghaei